June 2023 Newsletter

Tenants sharing their work with colleagues at our research campuses

and with the larger East Shore research cluster.

Sign your company up to get in front of this important research cluster and present at one of the two monthly Wareham in-person luncheon speaker series. The EmeryStation Research Campus speaker series is held on the first Thursday of every month. The Aquatic Park Research Campus speaker series is held on the third Thursday of each month. The presentations start promptly at noon with free bag lunches provided. Tenants from our research campuses and the local research community are all invited to attend both events.

Reserve your presentation date with Judy Wetterer at jwetterer@warehamdevelopment.com .

Summer Solstice celebration at our Point Richmond Tech Center

Tenant Appreciation Lunch.

Team members from (left to right) the CA Dept. of Justice--DNA Forensic Lab, Sangamo Therapeutics, and Nicholas Consulting Engineers kicked off summer activities with colleagues from Steris, Fidelity Information Services, the CA DOR, and Wareham for delicious barbeque and music.

Doing well by doing good.

Good news to share from the following tenants.

More info to be found on their websites. Congratulations to all!

4DMT presented positive interim data from Aerosolized 4D-710 Phase 1/2 AEROW Clinical Trial in Patients with Cystic Fibrosis at the ECFS 46th Annual Meeting.

Carmot Therapeutics raised $150 Million in Series E Equity Financing to Advance its Pipeline of Treatments for Obesity and Diabetes.

Catalent Pharma announced that it has expanded its integrated development, manufacturing and supply solution, OneBio^® Suite, across a range of biologic modalities, including antibody and recombinant proteins, cell and gene therapies, and mRNA.

Eureka Therapeutics was awarded a $10.6 Million CIRM Grant to support clinical trial of ARTEMIS® T-Cell Therapy in Pediatric Liver Cancer.

Gritstone Oncology announced the publication of interim results from an ongoing Phase 1 study evaluating their self-amplifying mRNA (samRNA) vaccines as a boost against #COVID19.

Kyverna Therapeutics was granted U.S. FDA Fast Track Designation for KYV-101 in Lupus Nephritis.

PhenomeX launched the Beacon Quest^™ optofluidic system, with Opto^® T Cell Profiling workflows for immunotherapy translational research.

Pivot Bio was named to the annual CNBC Disruptor 50 list, which highlights private companies that are chasing some of the market’s biggest opportunities, and growing despite a tough capital markets environment.

Sangamo Therapeutics received U.S. FDA Fast Track Designation for Isaralgagene Civaparvovec for the Treatment of Fabry Disease.

UPSIDE Foods received official clearance from the U.S. Department of Agriculture (USDA) to commercially produce and sell their cell-cultivated chicken in the United States.

.

Please continue to support these popular and loved restaurants serving our campuses and cities.

Check out their websites, call, or order from your favorite restaurant app. Many of them cater your lunches and meetings as well.

Conference rooms to reserve, fitness centers, bike parking and bike repair stations, pocket parks, art, and gardens may be found throughout our campuses.